Fluoxetine for Visual Recovery After Ischemic Stroke
Phase of Trial: Phase II
Latest Information Update: 20 Jul 2017
At a glance
- Drugs Fluoxetine (Primary)
- Indications Vision disorders
- Focus Therapeutic Use
- Acronyms FLUORESCE
- 16 Jul 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Jun 2020.
- 25 Oct 2016 Status changed from not yet recruiting to recruiting.
- 19 Apr 2016 New trial record